Bajaj healthcare has announced the appointment of Mr. Umeshkumar Laxmidas Bhavsar as Additional Director in the Non-Executive Independent Director category. The appointment, effective January 13, 2026, was approved through a Board resolution passed by circulation based on the recommendation of the Nomination & Remuneration Committee.

Appointment Details

The key parameters of Mr. Bhavsar's appointment are outlined below:

Professional Background

Mr. Umeshkumar Laxmidas Bhavsar brings extensive professional experience to the Board. As a qualified Chartered Accountant, he has accumulated over 35 years of experience across multiple sectors including real estate, financial services, retail, manufacturing, and consulting. His expertise encompasses strategic financial planning and corporate finance management, supported by deep domain knowledge and technical proficiency.

Career Highlights

Mr. Bhavsar's professional journey includes significant tenure with Ajmera Realty & Infra India Limited, where he served for more than 15 years in financial leadership roles. During this period, he played a crucial role in strategic decision-making processes for the organization. Currently, he serves as a Designated Partner at RUHN Global Advisory LLP, Mumbai, a firm that specializes in providing corporate and business strategic advisory services.

Regulatory Compliance

The appointment adheres to all regulatory requirements under the Companies Act, 2013, and SEBI regulations. Mr. Bhavsar has confirmed his compliance with the following criteria:

• Meets the criteria of 'Independence' under Section 149 of the Companies Act, 2013
• Satisfies requirements under Regulation 16 of SEBI Listing Regulations
• Has not been debarred from holding directorship by SEBI or other authorities
• Is not related to any existing Directors of the Company

The appointment follows the disclosure requirements under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring full transparency and regulatory compliance for the pharmaceutical company's governance structure.

Bajaj Healthcare Limited has announced the appointment of Mrs. Purnima Dhanraj Amin as Additional Director in the Non-Executive Independent Director category. The appointment was approved by the Board of Directors through a resolution passed by circulation on January 05, 2026, based on the recommendation of the Nomination & Remuneration Committee.

Appointment Details

The key details of Mrs. Amin's appointment are outlined below:

Professional Background and Expertise

Mrs. Purnima Dhanraj Amin brings extensive academic and research experience to the board. She is currently a Professor of Pharmacy at the Institute of Chemical Technology (ICT), Mumbai, Maharashtra. Her educational qualifications include a B. Pharma (Pharmacy), M. Pharma (Pharmaceutics) and Ph.D. (Tech.) in Pharmaceutics from the Institute of Chemical Technology.

With over 32 years of academic and research experience at ICT, Mumbai, Mrs. Amin currently serves as Vice President-Technological Association ICT and Dean-Student and Alumni Affairs. Her major research expertise lies in the application of Hot Melt Extrusion (HME) technology for the development of innovative drug delivery systems, covering oral, topical and parenteral formulations.

Industry Experience and Recognition

Mrs. Amin serves as a consultant to the Indian pharmaceutical industry, specializing in formulation development and evaluation of drug delivery systems. She has received numerous awards and recognitions for her contributions to pharmacy education and research. Additionally, she has authored several research publications in reputed scientific journals and holds life memberships in professional and educational organizations.

Compliance and Independence Confirmation

Mrs. Amin has confirmed that she meets the criteria of independence under Section 149 of the Companies Act, 2013, and Regulation 16 of the Listing Regulations. She has also confirmed that she has not been debarred from holding the office of Director by virtue of any order passed by the Securities and Exchange Board of India or any other such authority.

The company has disclosed that Mrs. Amin is not related to any of the existing Directors of the company, ensuring her independence in the role. The appointment has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.